159 related articles for article (PubMed ID: 11422498)
21. The immunohistochemical discrimination of endometrioid adenocarcinomas.
Dabbs DJ; Sturtz K; Zaino RJ
Hum Pathol; 1996 Feb; 27(2):172-7. PubMed ID: 8617459
[TBL] [Abstract][Full Text] [Related]
22. WT1 is an integral component of an antibody panel to distinguish pancreaticobiliary and some ovarian epithelial neoplasms.
Goldstein NS; Bassi D; Uzieblo A
Am J Clin Pathol; 2001 Aug; 116(2):246-52. PubMed ID: 11488072
[TBL] [Abstract][Full Text] [Related]
23. Mammaglobin expression in gynecologic adenocarcinomas.
Hagemann IS; Pfeifer JD; Cao D
Hum Pathol; 2013 Apr; 44(4):628-35. PubMed ID: 23084633
[TBL] [Abstract][Full Text] [Related]
24. Is immunostaining with HAM56 antibody useful in identifying ovarian origin of metastatic adenocarcinomas?
Cheung AN; Chiu PM; Khoo US
Hum Pathol; 1997 Jan; 28(1):91-4. PubMed ID: 9013838
[TBL] [Abstract][Full Text] [Related]
25. Value of a panel of antibodies to identify the primary origin of adenocarcinomas presenting as bladder carcinoma.
Torenbeek R; Lagendijk JH; Van Diest PJ; Bril H; van de Molengraft FJ; Meijer CJ
Histopathology; 1998 Jan; 32(1):20-7. PubMed ID: 9522212
[TBL] [Abstract][Full Text] [Related]
26. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
27. MSN-1 antibody in the evaluation of female genital tract adenocarcinomas.
Poropatich C; Nozawa S; Rojas M; Chapman WB; Silverberg SG
Int J Gynecol Pathol; 1990; 9(1):73-9. PubMed ID: 2294065
[TBL] [Abstract][Full Text] [Related]
28. Specificity of colon specific antigen and colon ovarian tumour antigen.
Dorman AM; Chin D; Leader M
J Clin Pathol; 1992 Oct; 45(10):932-3. PubMed ID: 1385484
[TBL] [Abstract][Full Text] [Related]
29. Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma.
Loy TS; Calaluce RD; Keeney GL
Mod Pathol; 1996 Nov; 9(11):1040-4. PubMed ID: 8933513
[TBL] [Abstract][Full Text] [Related]
30. Keratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary.
Wauters CC; Smedts F; Gerrits LG; Bosman FT; Ramaekers FC
Hum Pathol; 1995 Aug; 26(8):852-5. PubMed ID: 7543441
[TBL] [Abstract][Full Text] [Related]
31. Wilms tumor gene product: sensitive and contextually specific marker of serous carcinomas of ovarian surface epithelial origin.
Hwang H; Quenneville L; Yaziji H; Gown AM
Appl Immunohistochem Mol Morphol; 2004 Jun; 12(2):122-6. PubMed ID: 15354736
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical characterization of appendiceal mucinous neoplasms and the value of special AT-rich sequence-binding protein 2 in their distinction from primary ovarian mucinous tumours.
Strickland S; Parra-Herran C
Histopathology; 2016 Jun; 68(7):977-87. PubMed ID: 26542609
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibody, Mab 12C3, is a sensitive immunohistochemical marker of early malignant change in epithelial ovarian tumors.
Yamada K; Ohkawa K; Joh K
Am J Clin Pathol; 1995 Mar; 103(3):288-94. PubMed ID: 7872250
[TBL] [Abstract][Full Text] [Related]
34. CDX2 immunoreactivity in primary and metastatic ovarian mucinous tumours.
Fraggetta F; Pelosi G; Cafici A; Scollo P; Nuciforo P; Viale G
Virchows Arch; 2003 Dec; 443(6):782-6. PubMed ID: 14576939
[TBL] [Abstract][Full Text] [Related]
35. Comparison of glycoprotein expression between ovarian and colon adenocarcinomas.
Multhaupt HA; Arenas-Elliott CP; Warhol MJ
Arch Pathol Lab Med; 1999 Oct; 123(10):909-16. PubMed ID: 10506443
[TBL] [Abstract][Full Text] [Related]
36. Distinctive microvillous brush border staining with HBME-1 distinguishes pleural mesotheliomas from pulmonary adenocarcinomas.
Dahlstrom JE; Maxwell LE; Brodie N; Zardawi IM; Jain S
Pathology; 2001 Aug; 33(3):287-91. PubMed ID: 11523926
[TBL] [Abstract][Full Text] [Related]
37. Thyroid transcription factor-1 expression in ovarian epithelial neoplasms.
Kubba LA; McCluggage WG; Liu J; Malpica A; Euscher ED; Silva EG; Deavers MT
Mod Pathol; 2008 Apr; 21(4):485-90. PubMed ID: 18246044
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical characterization of a monoclonal antibody detecting an endometrioid ovarian cancer-associated antigen.
Giancotti FR; Dorsett BH; Kim KT; Ioachim HL; Barber HR
Int J Gynecol Pathol; 1990; 9(3):253-62. PubMed ID: 2197240
[TBL] [Abstract][Full Text] [Related]
39. Hepatocyte nuclear factor-1β is not a specific marker of clear cell carcinoma in serous effusions.
Davidson B
Cancer Cytopathol; 2014 Feb; 122(2):153-8. PubMed ID: 24115587
[TBL] [Abstract][Full Text] [Related]
40. CDX-2 immunostaining in primary and secondary ovarian carcinomas.
Tornillo L; Moch H; Diener PA; Lugli A; Singer G
J Clin Pathol; 2004 Jun; 57(6):641-3. PubMed ID: 15166272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]